BL-M02D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-M02D1, covering 2025-09-26 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors [Phase 1, Phase 2]

See pricing